XML 39 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
13. STOCKHOLDERS' EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Nov. 30, 2018
Equity [Abstract]  
Changes in the components of AOCI

Changes in the components of AOCI, net of tax, were as follows (in thousands):

 

    Cumulative Translation
Adjustments
    Unrealized Loss on
Investments, Net
    Total  
                   
Balance at May 31, 2018   $ 2,292     $ --     $ 2,292  
Other comprehensive (loss) income before reclassifications     (51 )     --       (51 )
Amounts reclassified out of AOCI     --       --       --  
Other comprehensive (loss) income, net of tax     (51 )     --       (51 )
Balance at November 30, 2018   $ 2,241     $ --     $ 2,241  

 

Compensation costs related to the Company's stock-based compensation

The following table summarizes the stock-based compensation expense for the three and six months ended November 30, 2018 and 2017 (in thousands):

 

    Three Months Ended     Six Months Ended  
    November 30,      November 30,  
    2018     2017     2018     2017  
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in:                        
Cost of sales   $ 23     $ 57     $ 59     $ 79  
Selling, general and administrative     136       218       284       368  
Research and development     65       89       137       133  
Total stock-based compensation   $ 224     $ 364     $ 480     $ 580  

 

Fair value assumptions for option valuation model

The fair value of the Company’s stock options granted to employees for the three and six months ended November 30, 2018 and 2017 were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:

 

    Three Months Ended     Six Months Ended  
    November 30,     November 30,  
    2018     2017     2018     2017  
                         
Expected term (in years)     5       4       5       4  
Volatility     0.70       0.74       0.72       0.77  
Risk-free interest rate     3.01 %     1.92 %     2.84 %     1.77 %
Weighted average grant date fair value   $ 1.21     $ 1.93     $ 1.38     $ 2.22  

 

The fair values of the ESPP purchase rights granted for the three and six months ended November 30, 2018 were estimated using the following weighted-average assumptions:

 

    Three and Six Months Ended
    November 30, 2018
     
Expected term (in years)   0.5-2.0
Volatility   0.48-0.64
Expected dividend   $0.00
Risk-free interest rates   2.40%-2.82%
Estimated forfeiture rate   0%
Weighted average grant date fair value   $1.15

 

Stock option and RSU transactions

The following tables summarize the Company’s stock option and RSU transactions during three and six months ended November 30, 2018 (in thousands):

 

    Available  
    Shares  
Balance, May 31, 2018     1,812  
         
  Options granted     (441 )
  RSUs granted     --  
  Shares cancelled     13  
  Shares expired     (11 )
         
Balance, August 31, 2018     1,373  
  Options granted     (248 )
  RSUs granted     --  
  Shares cancelled     45  
  Shares expired     (33 )
         
Balance, November 30, 2018     1,137  

 

Stock option transactions

The following table summarizes the stock option transactions during the three and six months ended November 30, 2018 (in thousands, except per share data):

 

    Outstanding Options  
          Weighted        
    Number     Average     Aggregate  
    of     Exercise     Intrinsic  
    Shares     Price     Value  
Balances, May 31, 2018     2,859     $ 2.04     $ 1,987  
                         
Options granted     441     $ 2.40          
Options cancelled     (13 )   $ 1.64          
Options exercised     (98 )   $ 1.12          
                         
Balances, August 31, 2018     3,189     $ 2.12     $ 1,757  
                         
Options granted     248     $ 2.03          
Options cancelled     (45 )   $ 2.70          
Options exercised     (19 )   $ 1.09          
                         
Balances, November 30, 2018     3,373     $ 2.11     $ 679  
                         
Options fully vested and expected to vest at November 30, 2018     3,337     $ 2.11     $ 678  

 

Options outstanding

The options outstanding and exercisable at November 30, 2018 were in the following exercise price ranges (in thousands, except per share data):

 

        Options Outstanding at November 30, 2018     Options Exercisable at November 30, 2018       
  Range of
Exercise Prices 
      Number Outstanding Shares     Weighted Average Remaining Contractual Life (Years)   Weighted Average Exercise Price    Number Exercisable Shares      Weighted Average Remaining Contractual Life (Years)     Weighted Average Exercise Price    Aggregate Intrinsic Value
    $0.59-$0.97        249       0.27     $ 0.66       249       0.27     $ 0.66        
    $1.09-$1.28        498       1.22     $ 1.28       498       1.22     $ 1.28        
    $1.68-$2.06        713       4.87     $ 1.84       344       3.53     $ 1.77        
    $2.10-$2.81        1,651       4.13     $ 2.43       1,143       3.13     $ 2.45        
    $3.46-$3.93        262       5.66     $ 3.86       114       5.72     $ 3.76        
    $0.59-$3.93        3,373       3.69     $ 2.11       2,348       2.61     $ 1.98     $ 653